0.45Open0.40Pre Close155 Volume50 Open Interest79.00Strike Price4.26KTurnover48.22%IV0.92%PremiumDec 13, 2024Expiry Date0.07Intrinsic Value100Multiplier1DDays to Expiry0.73Extrinsic Value100Contract SizeAmericanOptions Type-0.5101Delta0.2298Gamma108.87Leverage Ratio-0.4630Theta-0.0008Rho-55.54Eff Leverage0.0144Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet